Arvaya Healthcare Limited has scheduled a board meeting for October 24, 2026, to consider the preferential allotment of 38,71,854 equity shares to shareholders of Sushodha Institute of Gastroenterology Private Limited (SIGPL).

The allotment is proposed for consideration other than cash. This corporate action aims to consolidate interests with SIGPL stakeholders through equity issuance rather than monetary exchange.

Meeting Details and Regulatory Compliance

The company filed prior intimation with the Bombay Stock Exchange on October 17, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting agenda specifically includes the approval of this allotment.

Corporate Identity Update

The filing confirms that Arvaya Healthcare Limited was formerly known as Bijoy Hans Limited. The document is signed by Kaushal Uttam Shah, Managing Director, from Pune. No financial performance metrics or valuation details for the shares were disclosed in this intimation notice.

Arvaya Healthcare Limited concluded its 41st Annual General Meeting on September 21, 2026, with all five resolutions passed as ordinary resolutions by requisite majority, including approval for an intellectual property acquisition and a rights issue.

The meeting was held via video conferencing in compliance with Ministry of Corporate Affairs and SEBI circulars, commencing at 3:02 pm and concluding at 3:31 pm. Kaushal Uttam Shah, Managing Director, presided over the proceedings. A total of 3,492 shareholders were on record as of the cut-off date of September 14, 2026, with 22 shareholders attending through video conferencing — 3 from the promoter and promoter group, and 19 from the public. Remote e-voting ran from September 18 to September 20, 2026, facilitated through the National Securities Depository Limited (NSDL) platform.

Resolutions passed

Shareholders transacted the following items of business, all approved as ordinary resolutions:

• Adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026.
• Re-appointment of Kaushal Uttam Shah as Managing Director, who retires by rotation.
• Approval of material related-party transactions under Section 188 of the Companies Act, 2013, and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• Approval for the acquisition and assignment of the copyright and intellectual property portfolio of DEFIB Institute of Health Solutions LLP, funded from rights issue proceeds.

Voting results

The scrutinizer's report, dated September 22, 2026, confirmed that all resolutions secured the requisite majority. The table below summarises the consolidated voting outcome across all five resolutions.

For Resolutions 1 to 3, 100% of votes polled were cast in favour, with the promoter and promoter group contributing 14,703,679 votes via remote e-voting and public non-institutional holders contributing 18,104,142 votes. For Resolutions 4 and 5, the promoter and promoter group did not participate in voting as they were identified as interested parties; all valid votes were cast by public non-institutional holders, with 16,383,269 votes in favour representing 100% of valid votes polled.

Strategic updates

The Chairman highlighted several strategic developments during the meeting:

• Re-branding: The company officially transitioned to Arvaya Healthcare Limited to reflect its expanded focus in the healthcare sector.
• Subsidiary incorporation: Arvaya Insurance Broking Private Limited was incorporated as a wholly owned subsidiary on September 17, 2026, to diversify operations.
• Acquisition process: The company is acquiring Sushoda Institute of Gastroenterology Private Limited to expand its healthcare footprint.
• Capital raising: A rights issue of equity shares is underway to support these growth initiatives and strengthen balance sheet capacity.

CS Guinea Agrawal served as the convener and company secretary. Chinmay Mohan Lele, Practicing Company Secretary (FCS: 12351, CP: 28362), was appointed as scrutinizer for the e-voting process. The votes were unblocked at 5:28 pm on September 21, 2026, in the presence of two witnesses not in the employment of the company. The scrutinizer's report and voting results are available on the company's website at www.arvayahealth.com .